Iranian company expands portfolio of herbal medicines and supplements
۳۰ آبان ۱۴۰۵
13:34 - November 21, 2026

Iranian company expands portfolio of herbal medicines and supplements

داروی گیاهی
(Tehran Ana)- The company has developed a range of herbal products, including 95% pure turmeric extract, standardized cinnamon extract and a joint health supplement.
News ID : 11366

The company is pursuing the development of finished pharmaceutical products, supplements and natural health products, alongside the production of herbal and pharmaceutical raw materials with defined purity levels and quality standards.

Reza Torkashvand, the company's head of development, outlined its activities, explaining that the industrial and pharmaceutical manufacturer operates as a subsidiary of a major pharmaceutical group, with its work organized around research and development (R&D) and quality control (QC) units.

He said the company focuses on two main areas: developing finished medicines, supplements and natural products for the pharmaceutical group, and producing and developing pharmaceutical and herbal raw materials.

Highlighting some of its latest products, Torkashvand introduced Flat Joint, a specialized formulation designed to support joint health. The product combines several medicinal plant extracts with hyaluronic acid.

He also pointed to the company's production of high-purity herbal extracts, including turmeric curcuminoid extract with a purity level of 95%. Its cinnamon extract is also standardized according to its cinnamaldehyde content.

According to Torkashvand, these standardized extracts are used in the manufacture of medicines and dietary supplements. The cinnamon extract, in particular, is incorporated into products targeting cardiometabolic health, diabetes management and weight control.

The company also produces herbal extracts used in formulations for cold and cough relief. Hydroethanolic herbal extracts serve as active ingredients in the production of some of these products.

Torkashvand emphasized that the company's herbal raw materials are manufactured under the required regulatory approvals and are already being used in various pharmaceutical and supplement products.

He further highlighted the company's contribution to developing new products for the pharmaceutical group, noting that one of its products currently available on the market was developed at the company's R&D center and introduced commercially this year.

The head of development added that the company has several ongoing projects focused on developing new medicines and dietary supplements. Its activities extend beyond its current product portfolio to include further research and development of pharmaceutical formulations and plant-based raw materials.